WEEK OF SEPTEMBER 18, 2023
The Future of AI and Robotics in Healthcare
Japan Healthcare Week, featuring Conference Events in Nagoya (Sep. 19) and Tokyo (Sep. 21)
Japan Week Event on September 19, 2023
Nagoya Healthcare Forum
Sep 19, 2023
9am-5:35pm
Reception: 5:35-7:00pm
Nagoya Healthcare Forum
Nagoya Convention Hall (Link)
ヘルスケア領域は、AI、 IoT、ロボティックスに代表される技術革新を取り入れた新たな製品やサービスの開発が米国を筆頭にグローバルに進行し、ダイナミックな産業として躍進している。
新領域への挑戦の時中にある中部圏においても、高い技術力を有する企業やアカデミア独自のシーズをコア技術とするスタートアップが、成長産業であるヘルスケア領域へ参入し、新規事業の立ち上げを目指す動きは急速に増してきている。
本イベントは、同領域のイノベーションについて最先端の動向を知るのみでなく、先進的にエコシステムを形成し、ヘルスケア領域の革命的な変化において数々のイノベーションを創出する米国からの参加者らとのネットワーキングを通じたコネクション形成の絶好の機会である。
The healthcare field is making great strides as a dynamic industry, with the development of new products and services incorporating technological innovations such as AI, IoT, and robotics progressing globally, especially in the United States.
In the Chubu region, which is in the midst of taking on the challenge of entering new fields, companies with advanced technological capabilities and start-ups with core technologies based on seeds originally developed in academia are rapidly entering the growing healthcare field and aiming to launch new businesses.
This event is an excellent opportunity not only to learn about the latest trends in innovation in this area, but also to network and make connections with participants from the U.S., who have formed an advanced ecosystem and are creating numerous innovations in the revolutionary changes in the healthcare field.
Please see details on how to be a sponsor below
8:30 A.M. – 9:00 A.M.
REGISTRATION
9:00 A.M. – 9:30 A.M.
WELCOME AND OVERVIEW OF THE FORUM
Mr. Matthew Cenzer joined the State Department in 2002 and has focused on strengthening relationships with key U.S. allies and partners in Asia, as well as tackling critical international peace and security issues across the globe. He began his assignment in Nagoya in 2021. Prior to Nagoya, he served at U.S. Embassies in Manila, Jakarta, and Seoul, at the U.S. Mission to the United Nations in New York, and in Washington DC.
Steve Pollock assumed the position of President of Japan Society of Northern California on August 23, 2022. Previously a JSNC Board member, Mr. Pollock has been actively involved with a number of the Society’s signature initiatives, including starting JSNC’s operations in Japan in 2016, leading the corporate membership committee, and serving on the steering committee for the annual Innovation Awards.
9:30 A.M. – 10:15 A.M.
KEYNOTE SPEECH 1: THE AI REVOLUTION IN HEALTHCARE
Dr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Director/Founder of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA).
10:15 A.M. – 11:15 A.M.
KEYNOTE SPEECH 2 MOONSHOT SESSION
Dr. Shingo Shimoda holds the position of Designated Professor at Nagoya University, Graduate School of Medicine. His exploration of space robotics has led him to a profound recognition of the imperative for versatile intelligent systems, critical for harmonious human-robot coexistence. He is actively involved in crafting adaptive intelligent systems tailored for uncharted environments, drawing inspiration from biological control principles. His ultimate goal is to leverage this advanced intelligent system in the realm of rehabilitation.
11:15 A.M. – 12:00 P.M.
SESSION 1: THE FUTURE OF AI AND ROBOTICS IN HEALTHCARE
Dr. Shingo Shimoda holds the position of Designated Professor at Nagoya University, Graduate School of Medicine. His exploration of space robotics has led him to a profound recognition of the imperative for versatile intelligent systems, critical for harmonious human-robot coexistence. He is actively involved in crafting adaptive intelligent systems tailored for uncharted environments, drawing inspiration from biological control principles. His ultimate goal is to leverage this advanced intelligent system in the realm of rehabilitation.
Dr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Director/Founder of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA).
Ryan has spent 35 years in the Life Sciences and Medical Device industries focusing on innovation and adding value to the companies that drive it. He has worked with numerous companies that have invented novel technologies for a range of markets, including cell and gene therapies, biotherapeutics, biotech instrumentation, in vitro diagnostics, and medical devices. At Triple Ring Technologies, Ryan leads teams of world class scientists and engineers who work at the intersection of patient needs and cutting-edge technology development.
Dr. Eiryo Kawakami is a Team Leader at RIKEN and also a Professor at Chiba University, Graduate School of Medicine. Kawakami has introduced a wide range of mathematical methods into medical science research by collaborating with researchers in information and mathematical science fields. By using machine learning and mathematical analysis, he develops technologies that can predict and intervene before serious events such as severe illness or death occur.
Mr. Hitoshi Konosu joined Toyota Motor Corporation in 1986. After experiences on production engineering department and frontier research center, he is currently responsible for rehabilitation assist robot business project in new business planning division. He is interested in human-robot cooperation system. Driven by his profound passion for rehabilitation, he has enrolled in a Ph.D. program at Fujita Health University while juggling his responsibilities at Toyota and is diligently pursuing his Ph.D.
12:30 P.M. – 1:15 P.M.
LUNCHEON: BUSINESS EXECUTIVE FORUM
Dr. Hitoshi Hirata is a designated professor of the Department of Personalized Medical Technology at Nagoya University School of Medicine. His specialization lies in peripheral nerve surgery and functional reconstructive surgery. He served as a professor in the Department of Hand Surgery from 2007 to 2022. During this tenure, he actively fostered collaborative research between the fields of medicine and engineering, along with fostering partnerships between academia and industry.
Jack provides advisory services to companies and organizations, primarily early-stage ventures in the field of healthcare. He is also co-founder of US-Japan Medtech Frontiers, a nonprofit organization which recently joined with the Japan Society of Northern California (JSNC).
Dr. Burnett is a veteran in the medical device industry having founded many successful companies at various stages. During his undergraduate career at the University of Pennsylvania, he focused on bioengineering and spent a year at the Food and Drug Administration both testing devices and writing congressional reports on the current state-of-the-art devices. He then went on to Duke University where he completed his MD and his MBA. A licensed physician in the state of California, he finished his one-year internship at the Mayo Clinic in Jacksonville, Florida and matched for a residency in Ophthalmology at Stanford University which he deferred while he worked on starting his first venture, BAROnova.
1:30 P.M. – 2:15 P.M.
KEYNOTE SPEECH 3: INNOVATION FOR THE FUTURE OF ROBOTIC HEALTHCARE
Elton Satusky is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati. Elton represents both public and private enterprises as their outside general counsel and serves as a key strategic advisor from their inception throughout their life cycle. He advises on complex venture capital and corporate finance transactions, corporate law and governance, mergers and acquisitions, and public offerings.
Frank Litvack, M.D., FACC. Dr. Litvack is a native of Canada. He completed medical school and residency at McGill University in Montreal and a Cardiovascular Fellowship at Cedars-Sinai Medical Center in Los Angeles, where he subsequently became co-director of the Cardiovascular Intervention Center and Professor of Medicine at UCLA. There he led a prominent clinical and research program known for its excellence in innovation, care and leadership in Translational Medicine.
Read more here.
2:15 P.M. – 3:00 P.M.
SESSION 2: FRONTIERS IN DIGITAL SOLUTIONS AND ROBOTICS IN HEALTHCARE
Dr. Shingo Shimoda holds the position of Designated Professor at Nagoya University, Graduate School of Medicine. His exploration of space robotics has led him to a profound recognition of the imperative for versatile intelligent systems, critical for harmonious human-robot coexistence. He is actively involved in crafting adaptive intelligent systems tailored for uncharted environments, drawing inspiration from biological control principles. His ultimate goal is to leverage this advanced intelligent system in the realm of rehabilitation.
Nick Damiano is a serial medtech/healthtech entrepreneur. He is CEO & Co-founder of Andromeda Surgical, which is developing autonomous robots to improve surgical outcomes and efficiency. He was formerly CEO & Co-founder of Zenflow for 8 years, where he led the company’s prostatic implant from inception through successful late-stage clinical trials. He was also Co-founder & CTO of Nurep, later renamed Avail MedSystems, where he designed and built the company’s remote surgical support platform that is now used in hospitals throughout the US. Nick was a Stanford Biodesign Fellow and earned his MS & BS from Stanford University. He is also a Venture Partner at Pioneer Fund and a proud dad to two daughters.
Kanako Harada is an Associate Professor at the Center for Disease Biology and Integrative Medicine (CDBIM), Graduate School of Medicine, The University of Tokyo. She also holds positions in the Department of Bioengineering and the Department of Mechanical Engineering of the Graduate School of Engineering. In addition, she is the Project Manager for the Moonshot Project “Co-evolution of Human and AI-Robots to Expand Science Frontiers”.
Tom Kluz serves as the Managing Partner at Niterra Ventures, spearheading global investments on behalf of Niterra Co., LTD across medical, energy & environment, and mobility sectors. While he oversees investment endeavors in all these domains, Tom is particularly renowned for his deep expertise in healthcare. This distinction stems from a decade-long stint as the Head of Global Healthcare Investing at Qualcomm Ventures and a pivotal role at Providence Ventures.
Glenn Snyder is a Principal with Deloitte Consulting, LLP. He leads Deloitte’s Medical Technology practice. Glenn has been serving the life sciences and healthcare industry as a consultant since 1989 and has been with Deloitte since 1995, tackling issues and opportunities across the healthcare value chain over the course of his career, including the payor and provider sectors.
Glenn holds a Master of Business Administration in Finance and Strategic Management from the Wharton School of the University of Pennsylvania, a Master of Science in Engineering from the University of Southern California, and a Bachelor of Science in Engineering from Cal Poly, San Luis Obispo.
3:00 P.M. – 3:15 P.M.
SPECIAL SESSION
3:15 P.M. – 4:00 P.M.
SESSION 3: HOW TO DRIVE THE FUTURE OF HEALTHCARE THROUGH THE COLLABORATION OF US AND JAPAN
After graduating from Jichi Medical University, he began practicing general medicine in the rural areas of Japan. Fumiaki joined the Department of Cardiovascular Medicine at Stanford University in 2001, and was closely involved with the R&D, animal studies, and clinical studies of many medical device startups. He is also actively involved in projects with the US and Japanese regulatory agencies working to create an effective cross-border medical device eco-system. Fumiaki has also been an advisory faculty for the Stanford Biodesign Program since 2014. He is deeply involved with the development of the Japan Biodesign Program and is working diligently to establish a Silicon Valley-like medical device eco-system in Japan.
Mr. Matthew Cenzer joined the State Department in 2002 and has focused on strengthening relationships with key U.S. allies and partners in Asia, as well as tackling critical international peace and security issues across the globe. He began his assignment in Nagoya in 2021. Prior to Nagoya, he served at U.S. Embassies in Manila, Jakarta, and Seoul, at the U.S. Mission to the United Nations in New York, and in Washington DC.
Steve Pollock assumed the position of President of Japan Society of Northern California on August 23, 2022. Previously a JSNC Board member, Mr. Pollock has been actively involved with a number of the Society’s signature initiatives, including starting JSNC’s operations in Japan in 2016, leading the corporate membership committee, and serving on the steering committee for the annual Innovation Awards.
4:00 P.M. – 5:30 P.M.
STARTUP SHOWCASE
Javier Evelyn is the CEO and Founder of Alerje, a digital health company specializing in emergency medicine. Alerje is dedicated to improving the lives of over 220 million families worldwide living with food allergies by creating innovative solutions that help them make the most of every moment. In addition to being a founding member of MedTech Color, Javier serves on the boards of both the Accelerate Blue Fund at the University of Michigan and MATTER Health.
Ben Toker is a serial entrepreneur and technologist with strong commercial acumen and a focus on digital health.
He is currently the Co-Founder and CTO of Amaros – an AI-powered software platform to accelerate clinical studies and enable earlier treatment for vision care. Amaros predicts the progression of eye diseases based on industry-first Machine Learning algorithms that holistically integrate medical imaging, genomics, health data, and clinical studies.
Dana Cooney joined Digital Diagnostics as the VP of International Sales where she is responsible for developing and executing global commercialization plans for both on market and pipeline products, including partner relationships, licensee contracts, regulatory guidelines, adherence to country specific data management laws and regulations, KOL relationships, operations management, and reimbursement activities.
Eirini Schlosser is the Founder and CEO of Dyania Health, a fast-growing technology company focused on training natural language understanding (large language models) for medical grade performance in clinical research. She is leading a team of NLP Applied Scientists and Physicians, bridging computational acumen and medical expertise, to build Dyania Health’s Synapsis AI, an end-to-end systems adapted for various clinical support use cases.
Mr. Kim is a seasoned entrepreneur and strategist with various experiences in the healthcare sector.
Prior to taking head of Ficor, he has provided strategy and guidance to numerous companies doing
cross-border businesses, especially with the Middle East for almost 30 years.
Ryan has spent 35 years in the Life Sciences and Medical Device industries focusing on innovation and adding value to the companies that drive it. He has worked with numerous companies that have invented novel technologies for a range of markets, including cell and gene therapies, biotherapeutics, biotech instrumentation, in vitro diagnostics, and medical devices. At Triple Ring Technologies, Ryan leads teams of world class scientists and engineers who work at the intersection of patient needs and cutting-edge technology development.
Dr. Krawczyk is an advisor and investor with Level 42 AI. He obtained his PhD in Medicinal Chemistry at the University of Michigan at Ann Arbor with Dr. Leroy Townsend. After joining Gilead Sciences shortly after its founding, he worked on antisense research, aptamers, and small molecule antivirals. His research led to the publication of over 40 journal articles and patent applications.
Dean has over 25 years of experience in launching and growing brands in the areas of: medical devices, OTC health/wellness products, digital health apps, medical/pharmaceutical therapeutics, life science start-ups as well as Fortune 25 companies. Dean is the Founder & CEO of Mind Machine LLC, a strategic marketing and advertising agency in Silicon Valley. Before that role, Dean was a business advisor where he counseled life science and CPG companies regarding commercialization, market research, messaging, fundraising, crafting partnerships, building teams and developing products.
Dr. Rahaf Al Assil is the founder, Chair of the board, and the CEO of PantridgeDTell Corporations. Dr. Al Assil is a clinician scientist and an entrepreneur who has about 15 years of clinical practice in acute cardiac care and cardiometabolic medicine in Canada and oversees and just over 5 years in cardiac arrest academic and industrial research. She completed her clinical grad studies from Damascus university in 2008. She was first board certified in internal medicine in 2014 and is preparing for her next Canadian board certification in 2024. Dr. Assil completed a Master of Health Sciences/Clinical Methodology in 2019 and a research fellowship in cardiac arrest and resuscitation in 2021 form the University of British Columbia.
Kirk Zeller is a 25+ year veteran of the medical device industry with extensive global commercial experience having lived, worked, and studied in US, Europe, and Asia. Kirk has leveraged his Silicon Valley start-up experience and start-up focused research to start several companies including Progressive NEURO, Inc, ATS.Solutions, and MedMarket Access. Kirk is the Chief Business Officer for Radux Devices, LLC. Kirk currently serves on the boards of Radux Devices, MedMarket Access, and Progressive NEURO, Inc. Kirk received an award and was recognized by United States Congressman Adrian Smith for his entrepreneurial endeavors during COVID.
Mr. Lonsinger brings 25 years of medical sales and operations management to ViOptix. Mark comes from Philips Medical Systems, formerly ADAC Laboratories, where he was in charge of operations for the company’s nuclear medicine business. He previously was responsible for the sales operations and supply chain for the radiation therapy planning (RTP) and the positron emission tomography (PET) businesses. He has also held positions in manufacturing, project management, and finance. He was part of the ADAC team that won the Malcolm Baldrige award for quality assurance in 1996. Mark holds a BA in Economics from the University of California at Berkeley.
5:30 P.M. – 5:35 P.M.
5:35 P.M. – 7:00 P.M.
